Amgen Inc.
Latest Stories
on_the_money-prescription_drug_warranties_30471.jpg
FILE - This undated file image provided by Amgen Inc. shows the cholesterol-lowering drug Repatha. Warranties and money-back guarantees, long used to entice buyers of products like outdoor clothing and appliances, are now being used to sell something more vital: pricey new-generation drugs for diseases like rheumatoid arthritis and cancer. Drugmaker Amgen announced a deal the first week of May 2017 with insurer Harvard Pilgrim that will give the insurer a refund if a patient has a heart attack while on its $14,000-a-year cholesterol drug, Repatha. (Robert Dawson/Amgen via AP, File)
fda_drug_approvals_30471.jpg
FILE - This undated image provided by Amgen Inc. shows the cholesterol-lowering drug Repatha. Contrary to some political claims, the FDA actually approved more drugs, including Repatha, and three months faster on average, than European regulators did over the last five years. Three researchers reviewed approvals in the U.S. and Europe and published their results Wednesday, April 5, 2017, in the New England Journal of Medicine. (Robert Dawson/Amgen via AP, File)
cholesterol_drugs_98476.jpg
FILE - This undated image provided by Amgen Inc. shows the drug Repatha. The medicine cut the chances of having a heart attack or some other serious problems by 15 to 20 percent in a big study of people at high risk for those problems, released Friday, March 17, 2017, at an American College of Cardiology conference in Washington. (Robert Dawson/Amgen via AP, File)
